$AXTI

AXT Inc. (AXTI) rose 10.13% after Needham named it a semiconductor beneficiary of co-packaged optics. The firm sees CPO as crucial for AI networking. AXT reported Q2 revenue of $47.6M, up 165% YoY, with a 45% gross margin. Needham upgraded AXTI to Buy with a $90 target, and Northland raised its target to $125.

AXT Inc (NASDAQ: AXTI) shares rose 10.61% on September 16, 2026, driven by its addition to the S&P SmallCap 600 index. The company reported Q2 revenue of $47.59M, gross margin of 32.2%, and net income of $11.13M. AXTI has high valuation metrics, with a P/E above 2,800 and price-to-sales near 29.8. The stock has seen significant volatility, with leveraged ETFs and upcoming conferences adding to its momentum.

AXT, Inc. (AXTI) is expanding beyond China, with Europe, Asia-Pacific, Japan, and Taiwan showing significant revenue growth in 2026. Europe's revenue surged 302.3% YoY, while Asia-Pacific (excluding China, Taiwan, and Japan) grew 369.5%. Demand for InP substrates and export approvals support this expansion. China remains AXT's largest market but is expected to decrease to 40%-60% of revenues. North American revenues are constrained by export restrictions. The Zacks Consensus Estimate for 2026 re

AXT, Inc. (AXTI) shares rose 10.0% today, driven by investor interest in its indium phosphide business. The company reported Q2 2026 revenue of $47.6M, up from $26.9M, with record indium phosphide revenue. Recent supply deals with Coherent and Lumentum, totaling $65.8M in prepayments, also supported the stock's rise. Insiders sold shares, while hedge funds showed mixed activity.

The Tradr 2X Short AXTI Daily ETF (AXTQ) has seen significant volatility since its August 2026 launch, with AXT Inc. (AXTI) shares down 16.28% and AXTQ down 33.66% over a trailing week. AXTQ aims to deliver -200% of AXTI's daily performance, resetting each session. AXTI's sensitivity to US-China semiconductor trade policy and high volatility pose risks and opportunities for AXTQ traders. AXTI's revenue grew 164.8% year-over-year, with an analyst price target of $91.60. Traders should monitor pol

AXT, Inc. (AXTI) shares fell 22% in three months, underperforming peers. Despite challenges like export controls, demand for its indium phosphide (InP) substrates remains strong, with Q2 2026 substrate revenues up 232.7% YoY. AXTI is expanding InP capacity and has secured long-term supply agreements, positioning it for AI data-center optical demand growth. The stock trades at a premium P/S ratio of 34.85X.

Tradr ETFs launched the 2X Short AXTI Daily ETF (AXTQ), designed to deliver -200% of AXTI's daily return. AXTI, a semiconductor materials company, has surged 344% year-to-date but fell 18% last month. AXTQ's expense ratio is undisclosed, but similar funds typically charge 1% to 1.5% annually. The fund resets daily, risking volatility decay and potential total loss if AXTI rallies over 50% in a day.

AXT Inc. (NASDAQ:AXTI) shares rose 9.7% to $61.64, valuing the company at $4.04 billion, or 21.2 times annualized Q2 sales. Q2 revenue was $47.6 million, up 165% YoY, with gross margin at 44.9%. Interest income contributed 42.5% of net income. AXT has a long-term supply agreement with Lumentum Holdings (NASDAQ:LITE).

AXT Inc. (AXTI) rose 10.82% on September 4, 2026, driven by semiconductor growth prospects. The stock has shown high volatility, with significant intraday swings. AXTI reported $47.6M in quarterly revenue, a 32.2% gross margin, and a P/E ratio of 29.8. Leveraged ETFs (AXTX, AXTQ) amplify trading activity. The company is presenting at upcoming conferences, which may impact sentiment.

U.S. stock futures rose late Thursday as oil prices cooled and war fears eased. SMCI shares fell 12% after legal charges, PL surged 15% on strong Q4 results, FDX rose 9% on earnings beat, AXTI hit a record high, and SLS edged higher on narrowed losses. Dow, S&P 500, and Nasdaq closed lower but recovered from steeper losses.